QNTM (Quantum BioPharma) Total Assets : $19.03 Mil (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Quantum BioPharma Total Assets?

Quantum BioPharma's Total Assets for the quarter that ended in Sep. 2024 was $19.03 Mil.

During the past 12 months, Quantum BioPharma's average Total Assets Growth Rate was -14.60% per year. During the past 3 years, the average Total Assets Growth Rate was -15.70% per year. During the past 5 years, the average Total Assets Growth Rate was -10.80% per year.

During the past 9 years, Quantum BioPharma's highest 3-Year average Total Assets Growth Rate was 2083.10%. The lowest was -16.00%. And the median was -5.80%.

Total Assets is connected with ROA %. Quantum BioPharma's annualized ROA % for the quarter that ended in Sep. 2024 was -89.33%. Total Assets is also linked to Revenue through Asset Turnover. Quantum BioPharma's Asset Turnover for the quarter that ended in Sep. 2024 was 0.00.

Quantum BioPharma Total Assets Historical Data

The historical data trend for Quantum BioPharma's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum BioPharma Total Assets Chart

Quantum BioPharma Annual Data

Trend

Aug15

Aug16

Aug17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

43.22

41.97

62.96

38.41

17.48

Quantum BioPharma Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Assets	Get a 7-Day Free Trial															18.94	17.48	15.44	15.25	19.03

Quantum BioPharma Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Quantum BioPharma's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	12.909	+	4.566
	=	17.48

Quantum BioPharma's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets	=	Total Equity (Q: Sep. 2024 )	+	Total Liabilities (Q: Sep. 2024 )
	=	15.346	+	3.681
	=	19.03

Quantum BioPharma (NAS:QNTM) Total Assets Explanation

Total Assets is connected with ROA %.

Quantum BioPharma's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %	=	Net Income (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
	=	-15.308	/	( (15.247	+	19.027)	/ 2 )
	=	-15.308	/	17.137
	=	-89.33 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Quantum BioPharma's Asset Turnover for the quarter that ended in Sep. 2024 is

	Asset Turnover
=	Revenue (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
=	0	/	( (15.247	+	19.027)	/ 2 )
=	0	/	17.137
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Quantum BioPharma Total Assets Related Terms

Thank you for viewing the detailed overview of Quantum BioPharma's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Quantum BioPharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Quantum BioPharma Ltd (NAS:QNTM) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

0K91:Germany QNTM:Canada

Address

199 Bay Street, Suite 4000, Toronto, ON, CAN, M5L 1A9

Website

https://www.fsdpharma.com

Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.